Provided by Tiger Trade Technology Pte. Ltd.

Capital Research Global Investors

2,926.50
+15.920.55%
Number of Gainers:57
Number of Losers:38
Number of Flat:- -
PE:- -
High:2,934.61
Open:2,910.76
Low:2,902.77
Close:2,910.58
Volume:745.89M
Turnover:159.24B
Market Cap:33.43T
Float Cap:31.77T

Loading ...

CME Reports August Average Daily Volume Rises 6% to 30 Million Contracts

Reuters
·
Sep 02

JPMorgan Trims Stake in China Suntien, Offloading 2.37 Million Shares at HK$3.26 Each

Stock News
·
Sep 02

Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings

Benzinga Earnings
·
Sep 02

CME Group Reports Second-Highest August Adv of 29.7 Million Contracts

THOMSON REUTERS
·
Sep 02

Berkshire CEO Abel Sees Opportunity for Energy Business from AI

Reuters
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

AIG's Zaffino Stepping Down as Chairman, Joining Palantir

Dow Jones
·
Sep 02

AMD or RKLB: Cathie Wood Sells $3.4M of One Stock, Buys $31.6M of the Other

TIPRANKS
·
Sep 02

Liquefied Gas Shipper BW LPG Slides After $300 Mln Convertible Bond Offering

Reuters
·
Sep 02

Apple Grants Cook $47 Million Pay Package as He Transitions to Executive Chairman Role

Deep News
·
Sep 02

American International Group Names John Rice as Chair

MT Newswires Live
·
Sep 02

New Apple Chief Makes Debut on Chinese Social Media Within Hours of Taking the Helm

Deep News
·
Sep 02

Protagonist Therapeutics CEO Patel Joins Fireside Chats at Two Investment Bank Conferences

Reuters
·
Sep 02

Teva: Tev '408 was Well-Tolerated with no Safety Signals Observed to Date

THOMSON REUTERS
·
Sep 02

Teva - Tev ‘408 Demonstrates Statistically Significant Prevention of Gluten-Induced Damage in Phase 2a Study

THOMSON REUTERS
·
Sep 02

Teva - Phase 2a Study Meets Primary Endpoint with Significant Prevention of Gluten-Induced Damage

THOMSON REUTERS
·
Sep 02

CASI Pharmaceuticals Sells Alesta Stake to BioMarin for Us$5.9 Million

Reuters
·
Sep 02

Medtronic Plc : Leerink Partners Raises Target Price to $111 from $104

THOMSON REUTERS
·
Sep 02

EyePoint to Join Citi, Cantor and Morgan Stanley Healthcare Investor Conferences

Reuters
·
Sep 02

Morgan Stanley Reaffirms Their Buy Rating on Apple (AAPL)

TIPRANKS
·
Sep 02